Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,331 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Saikosaponins: a review of pharmacological effects.
Li XQ, Song YN, Wang SJ, Rahman K, Zhu JY, Zhang H. Li XQ, et al. Among authors: wang sj. J Asian Nat Prod Res. 2018 May;20(5):399-411. doi: 10.1080/10286020.2018.1465937. Epub 2018 May 4. J Asian Nat Prod Res. 2018. PMID: 29726699 Review.
Chinese Herbal Formulas and Renal Fibrosis: An Overview.
Shen YL, Wang SJ, Rahman K, Zhang LJ, Zhang H. Shen YL, et al. Among authors: wang sj. Curr Pharm Des. 2018;24(24):2774-2781. doi: 10.2174/1381612824666180829103355. Curr Pharm Des. 2018. PMID: 30156149 Review.
ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway.
Shen YL, Jiang YP, Li XQ, Wang SJ, Ma MH, Zhang CY, Zhu JY, Rahman K, Zhang LJ, Luan X, Zhang H. Shen YL, et al. Among authors: wang sj. Front Pharmacol. 2020 Jan 24;10:1596. doi: 10.3389/fphar.2019.01596. eCollection 2019. Front Pharmacol. 2020. Retraction in: Front Pharmacol. 2024 Dec 02;15:1530375. doi: 10.3389/fphar.2024.1530375 PMID: 32038260 Free PMC article. Retracted.
Isorhamnetin: A review of pharmacological effects.
Gong G, Guan YY, Zhang ZL, Rahman K, Wang SJ, Zhou S, Luan X, Zhang H. Gong G, et al. Among authors: wang sj. Biomed Pharmacother. 2020 Aug;128:110301. doi: 10.1016/j.biopha.2020.110301. Epub 2020 Jun 2. Biomed Pharmacother. 2020. PMID: 32502837 Free article. Review.
Corrigendum: ErHuang Formula Improves Renal Fibrosis in Diabetic Nephropathy Rats by Inhibiting CXCL6/JAK/STAT3 Signaling Pathway.
Shen YL, Jiang YP, Li XQ, Wang SJ, Ma MH, Zhang CY, Zhu JY, Rahman K, Zhang LJ, Luan X, Zhang H. Shen YL, et al. Among authors: wang sj. Front Pharmacol. 2021 Nov 18;12:789192. doi: 10.3389/fphar.2021.789192. eCollection 2021. Front Pharmacol. 2021. Retraction in: Front Pharmacol. 2024 Dec 02;15:1530384. doi: 10.3389/fphar.2024.1530384 PMID: 34867422 Free PMC article. Retracted.
CXCL6 Promotes Renal Interstitial Fibrosis in Diabetic Nephropathy by Activating JAK/STAT3 Signaling Pathway.
Sun MY, Wang SJ, Li XQ, Shen YL, Lu JR, Tian XH, Rahman K, Zhang LJ, Nian H, Zhang H. Sun MY, et al. Among authors: wang sj. Front Pharmacol. 2019 Mar 25;10:224. doi: 10.3389/fphar.2019.00224. eCollection 2019. Front Pharmacol. 2019. Retraction in: Front Pharmacol. 2024 Dec 05;15:1530358. doi: 10.3389/fphar.2024.1530358 PMID: 30967776 Free PMC article. Retracted.
3,331 results